Intellect Neurosciences Inc. (fka ILNS)

[NOPRESSURE]

You are so emotionally caught up in this that you are relying on your imagination to understand events. PFIZER STOPPED (IS A CORRECT STATEMENT) USING PONEZIMAB BY THE TIME THE CASE WAS LODGED AGAINST THEM IN 2012 THAT IS THE CONTEXT IN WHICH THE DEFENCE RELAYED THEIR MESSAGE.

AND THAT WHETHER THEY'RE USING PONEZUMAB OR NOT IS NOT A FACTOR TO THE PLAINTIFF OR DEFENCE, ANOTHER POINT YOU SEEMED TO HAVE MISSED. PLAINTIFF IS STATING PONEZUMAB IS THE COMPOUND CONTAINED IN THE CONTRACT WHETHER DEFENDANTS USED IT OR NOT IS IMMATERIAL.

THE PLAINTIFF FACT IS THAT THE GRANT OF THE PATENT FOR PONEZUMAB IS COVERED IN THE COMPOUND HENCE TRIGGERING THE MILESTONE PAYMENT. DEFENCE IS SAYING WHAT PONEZUMAB? THE DEFENCE SAYS THE WORD PONEZUMAB DOES NOT EXIST IN CONTRACT AND THAT CONTRACT SAYS WOULD INFRINGE NOT WILL INFRINGE you have a long way to go in grasping the issues. that summarizes the issues. THIS CASE IS ABOUT BREACH OF CONTRACT REGARDING CONTRACT TERMS, NOT A PHYSICAL (USING PONEZUMAB) BREACH BY THE DEFENCE. I would venture to say a settlement in this case may only exist in "fairy land" WOULDN'T ADVISE HOLDING YOUR BREATH.

STOP SITTIN ON THE EDGE OF YAH SEAT IT AIN'T HAPPENIN AS FAST THAT, RELAX WE HAVE A WAYS TO GO.